Managing Director
Christian Nicks is an investment banker with over 20 years’ experience working in Australia, the United States, Japan, Hong Kong, and the United Kingdom.
Director
Analyst
Srisatwik Bhogadi has experience across corporate advisory and investment banking including capital raisings and sell-side and buy-side M&A across various sectors including government services, healthcare and industrials.
Managing Director
Christian Nicks is an investment banker with over 20 years’ experience working in Australia, the United States, Japan, Hong Kong, and the United Kingdom. Christian spent over ten years at Goldman Sachs working in the healthcare, telecoms, industrials, financial sponsors and mining sectors.
He has advised on some of the largest transactions in the healthcare sector in Australia, including the A$2.6 billion private equity takeover battle for Healthscope, the A$2.7 billion leveraged take private of DCA by CVC Capital Partners, Healthscope’s A$3.6 billion joint bid for Symbion Health, the A$1.1 billion sale of DCA Aged Care by CVC Capital Partners and Aspen Pharmacare’s A$900 million acquisition of the pharmaceutical business of Sigma Pharmaceuticals Limited.
In 2010, Christian left Goldman Sachs to become Head of Investment Banking at Investec Australia, where he led a team of 35 professionals to substantially grow Investec’s advisory business. While at Investec, he initiated and advised on the A$1.1 billion acquisition of Spotless Limited by Pacific Equity Partners. The transaction employed several novel takeover techniques, was remarked to set the “high water mark for hostility in Private Equity takeovers in Australia”, and was ultimately successful after a campaign fought with the support of institutional shareholders. He also advised on the A$880 million sale of Ingham Enterprises to TPG, the sale of Supre Holdings to Cotton On, and advised Perpetual on its response to an unsolicited A$1.8 billion takeover approach from KKR.
Christian left Investec in 2014 to establish VCA. Christian graduated from Stanford University with a Bachelor of Arts in Economics. He is a Member of the Australian Institute of Company Directors, an Advisory Board Member for Human Rights Watch Australia, a dual US/Australian citizen and an avid sailor.
Ben has advised on a broad range of M&A transactions, including Toll Group’s sale of Toll Global Express to Allegro, 7-Eleven International’s acquisition of 7-Eleven Australia and the sale of George Clinical to Hillhouse.
Prior to VCA Partners, Ben worked at Bank of America as a vice-president in the Consumer, Retail and Healthcare investment banking team. Ben has also worked in investment banking at Nomura and Blackpeak Capital after commencing his career at Ernst & Young.
Ben has a Bachelor of Business (Management) and Bachelor of Engineering (Civil) from the University of Newcastle, Masters of Applied Finance from Macquarie University and is a qualified Chartered Accountant.
Noah Rooney has over 5 years’ experience spanning investment banking, consulting and law. Noah’s investment banking experience includes domestic and cross-border buy-side and sell-side M&A transactions, undertaking strategic portfolio reviews for global businesses to identify M&A and divestment opportunities, and capital raising activities.
Previously, Noah’s work in the consulting and legal professions expanded his exposure across different M&A and capital market workstreams completing commercial, financial and legal due diligence, as well as more operational contract negotiations, dispute resolution and intellectual property matters.
Noah has advised on Toll Group’s acquisition of Pel-Air from Rex Group, the sale of Pacific Aerospace Consulting to Aurizn (backed by Pemba Capital), and the sale of Athena AI to SightLine Applications (backed by Artemis).
Noah has a Bachelor of Business (Finance Major, Economics Minor) and Bachelor of Laws (Honours) from the Queensland University of Technology.
Lachlan Holman is an investment banker with over 3 years’ experience. His experience spans M&A, equity and debt capital markets, and restructuring in the healthcare, private equity, and general industrials sectors. Prior to joining VCA Partners, Lachlan worked at long/short hedge fund, Antipodes, as an Investment Analyst in the Global Healthcare Team.
Before Antipodes, Lachlan worked as an Investment Banking Analyst at Evolution Capital, specialising in Equity Capital Markets for SMID-cap ASX clients across healthcare, mining, and emerging technology.
Lachlan has advised on Toll Group’s acquisition of Pel-Air from Rex Group, Macquarie Asset Management’s acquisition of Linen Services Australia from Adamantem Capital, and Healthe Care’s commercial negotiations regarding radiology arrangements.
Lachlan has a Bachelor of Economics and is currently pursuing an Advanced Studies degree in Medicinal Chemistry and Biotechnology at the University of Sydney.
Srisatwik Bhogadi has experience across corporate advisory and investment banking including capital raisings and sell-side and buy-side M&A across various sectors including government services, healthcare and industrials.
Prior to joining VCA, Srisatwik’s corporate advisory experience allowed him to gain expertise across strategy consulting and debt capital markets. He has also tutored economics at the University of New South Wales.
Srisatwik is currently pursuing a Bachelor of Actuarial Studies and a Bachelor of Commerce (Finance) from the University of New South Wales.